PX-12 (1-methylpropyl 2-imidazolyl disulfide) irreversibly inactivates Trx-1 and the antitumor activity can be synergistically enhanced after combination of PX-12 with 5-FU in HCC cells [58]. Here, TXN is linked to hepatocellular carcinoma.